Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.

about

Risk of chemotherapy-induced febrile neutropenia by day of pegfilgrastim prophylaxis in US clinical practice from 2010 to 2015.Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

P2860

Q47668200-3DA204FA-417A-46C7-BC8E-1350F73D3518 Q58767839-E078A27E-5E3E-4C92-9E47-383EC8404513

P2860

Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.

Item

http://www.wikidata.org/entity/Q39297322

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Burden of Chemotherapy-Induced ...... ith Colony-Stimulating Factor.

@en

Burden of Chemotherapy-Induced ...... ith Colony-Stimulating Factor.

@nl

type

Item

label

Burden of Chemotherapy-Induced ...... ith Colony-Stimulating Factor.

@en

Burden of Chemotherapy-Induced ...... ith Colony-Stimulating Factor.

@nl

prefLabel

Burden of Chemotherapy-Induced ...... ith Colony-Stimulating Factor.

@en

Burden of Chemotherapy-Induced ...... ith Colony-Stimulating Factor.

@nl

P1476

Burden of Chemotherapy-Induced ...... ith Colony-Stimulating Factor.

@en

P2093

Derek Weycker

http://www.w3.org/2001/XMLSchema#string

Gary H Lyman

http://www.w3.org/2001/XMLSchema#string

Jacob Garcia

http://www.w3.org/2001/XMLSchema#string

Mark Atwood

http://www.w3.org/2001/XMLSchema#string

Maureen Reiner

http://www.w3.org/2001/XMLSchema#string

Spiros Tzivelekis

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Li

http://www.w3.org/2001/XMLSchema#string

Yanli Li

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of pegfilgrastim prescribing practice to national guidelines at a university hospital outpatient oncology clinic.

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.

Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies.

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases.

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.

Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes.

P2888

s00520-016-3421-x

P304

439-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-016-3421-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27734153

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy-induced febrile neutropenia

Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.

about

P2860

P2860

Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921